NBC 4 Reno / Tahoe (KRNV): Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease
Phase 2 randomized, open-label study to assess the safety, tolerability and preliminary efficacy of its investigational drug, Plicera(TM) (afegostat tartrate), in treatment-naive adult patients with type 1 Gaucher disease. Two dose regimens of Plicera (225 mg three days on/four days off and...
-
- Share:
-
-
-
-
-
-
Reach -
Credibility
-
News Stories
- News Source: Uinta County News | about 1 month agoAmicus Therapeutics on Friday reported disappointing results for its Gaucher disease drug candidate Plicera, as the drug did not appear to work for 18 of the 19 patients in a midstage clinical trial. The six-month study showed Plicera was safe, but...
- News Source: Uinta County News | about 1 month agoPhase 2 randomized, open-label study to assess the safety, tolerability and preliminary efficacy of its investigational drug, Plicera(TM) (afegostat tartrate), in treatment-naive adult patients with type 1 Gaucher disease. Two dose regimens of...
Post a Comment Comments: 0
Cell phones use report code: Most Popular Reports
Site Links
Site Topics
Contributions
- Report Your News
- Add your voice and contribute via your cellphone - check out how to Report News via Your Cellphone
- Blog Widget
- Widget for Blog Owner
